Alzamend Neuro, Inc. Common Stock (ALZN) is a publicly traded Healthcare sector company. As of May 21, 2026, ALZN trades at $1.24 with a market cap of $3.88M and a P/E ratio of -0.09. ALZN moved +23.76% today. Year to date, ALZN is -41.46%; over the trailing twelve months it is -65.91%. Its 52-week range spans $0.84 to $17.10. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces ALZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ALZN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ALZN recently traded at $1.24. Market cap is $3.88M. P/E ratio is -0.09. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.24 |
| Market Cap | $3.88M |
| P/E Ratio | -0.09 |
| EPS | $-11.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.10 |
| 52-Week Low | $0.84 |
| Volume | 167.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $4.50M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $4.50M | $-11.32 |
| 2024 | $0 | $9.90M | $-14.70 |
| 2023 | $0 | $14.90M | $-0.15 |
| 2022 | $0 | $-12.36M | $0.00 |
1 analysts cover ALZN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.